NCT05680454 2023-01-17A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV VaccineBeijing Health Guard Biotechnology, IncPhase 1 Completed160 enrolled
NCT05672966 2023-01-06Phase I Clinical Trial of a Candidate HPV VaccineWuhan BravoVax Co., Ltd.Phase 1 Unknown40 enrolled